loadpatents
Patent applications and USPTO patent grants for Cramer; Daniel.The latest application filed is for "autoantibody biomarkers for the early detection of ovarian cancer".
Patent | Date |
---|---|
Autoantibody Biomarkers For The Early Detection Of Ovarian Cancer App 20220163531 - Katchman; Benjamin ;   et al. | 2022-05-26 |
Autoantibody biomarkers for the early detection of ovarian cancer Grant 11,243,208 - Katchman , et al. February 8, 2 | 2022-02-08 |
Autoantibody Biomarkers For The Early Detection Of Ovarian Cancer App 20190302122 - Katchman; Benjamin ;   et al. | 2019-10-03 |
Autoantibody Signature for the Early Detection of Ovarian Cancer App 20150362497 - Anderson; Karen ;   et al. | 2015-12-17 |
Urinary CA125 peptides as biomarkers of ovarian cancer Grant 8,642,347 - Ye , et al. February 4, 2 | 2014-02-04 |
CA-125 Immune Complexes as Biomarkers of Ovarian Cancer App 20120295814 - Cramer; Daniel ;   et al. | 2012-11-22 |
Urinary CA125 Peptides as Biomarkers of Ovarian Cancer App 20110045508 - Ye; Bin ;   et al. | 2011-02-24 |
Ginkgolides in the Treatment and Prevention of Ovarian Cancer App 20090099102 - Ye; Bin ;   et al. | 2009-04-16 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.